This archive includes all weekly updates of the figures on the COVID-19 vaccination programme in the Netherlands.
20 December 2022 | 16:00
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September up to and including 18 December 2022, nearly 4 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 58.1%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.
Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 50 (2022). 1-2
Age group | Birth year | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
12 years and older | 2010 and before | 25.4% | 31.6% |
18 years and older | 2004 and before | 27.3% | 33.2% |
60 years and older | 1962 and before | 58.1% | 62.4% |
- Source: CIMS+ method
- The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..
6 December 2022 | 16:20
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September up to and including 4 December 2022, more than 3.8 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 57.3%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.
Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 48 (2022). 1-2
Age group | Birth year | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
12 years and older | 2010 and before | 24.9% | 31.0% |
18 years and older | 2004 and before | 26.8% | 32.5% |
60 years and older | 1962 and before | 57.3% | 61.5% |
- Source: CIMS+ method
- The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..
29 November 2022 | 16:00
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September up to and including 27 November 2022, more than 3.8 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 56.6%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.
Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 47 (2022). 1-2
Age group | Birth year | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
12 years and older | 2010 and before | 24.5% | 30.5% |
18 years and older | 2004 and before | 26.3% | 32.0% |
60 years and older | 1962 and before | 56.6% | 60.8% |
- Source: CIMS+ method
- The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..
22 November 2022 | 16:00
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September up to and including 20 November 2022, more than 2.7 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 55.5%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.
Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 46 (2022). 1-2
Age group | Birth year | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
12 years and older | 2010 and before | 23.9% | 29.7% |
18 years and older | 2004 and before | 25.7% | 31.2% |
60 years and older | 1962 and before | 55.5% | 59.5% |
- Source: CIMS+ method
- The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..
15 November 2022 | 16:00
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September up to and including 15 November 2022, 3.6 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54.2%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients.
Everyone aged 12 years and older now has the option to get a repeat vaccination against COVID-19. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.
Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 45 (2022). 1-2
Age group | Birth year | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
12 years and older | 2010 and before | 23.0% | 28.6% |
18 years and older | 2004 and before | 24.8% | 30.1% |
60 years and older | 1962 and before | 54.2% | 58.1% |
- Source: CIMS+ method
- The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.
8 November 2022 | 16:00
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September up to and including 6 November 2022, 3.4 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 52.1%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients.
Everyone aged 12 years and older now has the option to get a repeat vaccination against COVID-19. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. You can make an appointment via planjeprik.nl. Walk-in vaccinations are also possible at more and more locations. For more information, see www.prikkenzonderafspraak.nl.
Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 44 (2022). 1-2
Age group | Birth year | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
12 years and older | 2010 and before | 21.7% | 26.9% |
18 years and older | 2004 and before | 23.4% | 28.3% |
60 years and older | 1962 and before | 52.1% | 55.8% |
- Source: CIMS+ method
- The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..
1 November 2022 | 16:30
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September up to and including 30 October 2022, more than 3 million repeat vaccinations against COVID-19 were administered. Vaccination coverage for the repeat vaccination among people over 60 has now reached 48.7%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.
Everyone aged 12 years and older now has the option to get a repeat vaccination against COVID-19. You can make an appointment via planjeprik.nl.
The data flow between GGD-GHOR and RIVM was on hold for a short period. This was due to the preparations for data transfer related to the vaccinations in autumn 2022. Starting tomorrow, RIVM will share open data about COVID-19 vaccination coverage for the repeat vaccination in autumn 2022.
Table 1. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, completed basic series, week 38 (2022) to week 43 (2022). 1-2
Age group | Birth year | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
12 years and older | 2010 and before | 19.4% | 24,0% |
18 years and older | 2004 and before | 20.9% | 25.3% |
60 years and older | 1962 and before | 48.7% | 52.1% |
- Source: CIMS+ method
- The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.
25 October 2022 | 16:00
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September to 23 October 2022, nearly 2.5 million repeat vaccinations against COVID-19 were administered. Last week, similar to the week before, most of the repeat vaccinations administered were in the age group of 60 years and older. Vaccination coverage for the repeat vaccination among people over 60 has now reached 42.4%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.
As of this week, everyone aged 12 years and older will have the option to get a repeat vaccination against COVID-19. It will be made available step by step, according to birth year. More information is provided at Government.nl.
The data flow between GGD-GHOR and RIVM was on hold for a short period. This was due to the preparations for data transfer related to the vaccinations in autumn 2022. The weekly update on participation in COVID-19 vaccination in the Netherlands was published in PDF format this week. The expectation is that data on COVID-19 vaccination coverage can be shared through our COVID-19 dataset again as of next week.
Table 1. Number of people vaccinated in the autumn 2022 round (COVID-19 basic series or repeat vaccination), week 38 (2022) to week 42 (2022), by type of vaccinator. 1-2
Vaccinator | First dose in basic series | Second dose in basic series | Repeat vaccination against COVID-19 |
---|---|---|---|
Municipal Public Health Services (GGD) | 2,018 | 1,162 | 2,437,443 |
GPs | 3 | 0 | 11,195 |
Other | 25 | 12 | 43,186 |
Total | 2,046 | 1,174 | 2,491,824 |
- Source: CIMS/CoronIT (Municipal Public Health Services – GGD) and CIMS+ (general practitioners and other vaccinators)
- The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection..
18 October 2022 | 17:00
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September to 16 October 2022, nearly 1.9 million repeat vaccinations against COVID-19 were administered. Most of the repeat vaccinations administered last week were in the age group of 60 years and older. Vaccination coverage for the repeat vaccination among people over 60 has now reached 33.8%. Vaccination coverage among people over 70 is now 45.8%, and among people over 80 it has reached 45.5%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.
Starting this week, people under 60 will also have the option to get a repeat vaccination against COVID-19. It will be made available step by step, according to birth year. More information is provided at Government.nl.
Table 1. Number of repeat vaccinations against COVID-19 in the autumn round, week 38 to week 41, 20221-3
Week | Cumulative number of repeat vaccinations against COVID-19 |
---|---|
38 | 262,389 |
39 | 716,138 |
40 | 1,280,663 |
41 | 1,893,265 |
- Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
- People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
- People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in these figures. Therefore, these figures are slightly lower than the actual total.
Table 2. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, week 38 to week 41, 2022 1-3
Age group | Birth years | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
60 years and older 70 years and older |
1962 and before 1952 and before |
33.8 % 45.8 % |
37.1 % 49.2 % |
- Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
- People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
- People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in the numerator. Therefore, these vaccination coverage figures are slightly lower than the actual totals.
The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. It is therefore not yet possible to provide a weekly update on participation in COVID-19 vaccination in the Netherlands.
11 October 2022 | 17:00
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September to 9 October 2022, more than 1.2 million repeat vaccinations against COVID-19 were administered. Most of the repeat vaccinations administered last week were in the age group of 70 years and older Vaccination coverage for the repeat vaccination among people over 70 has now reached 36.2%, and among people over 70 it is now 38.1%.
The repeat vaccination is now available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.
Starting from 4 October 2022, people aged 12 to 59 years who are eligible for the seasonal flu jab receive an invitation from their GP. More information about COVID-19 vaccination, who will be invited and when is provided at Government.nl.
Table 1. Number of repeat vaccinations against COVID-19 in the autumn round, week 38 to week 40, 20221-3
Week | Cumulative number of repeat vaccinations against COVID-19 |
---|---|
38 | 261,887 |
39 | 711,470 |
40 | 1,267,913 |
- Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
- People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
- People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in these figures. Therefore, these figures are slightly lower than the actual total.
Table 2. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, week 38 to week 40, 2022 1-3
Age group | Birth years | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
60 years and older 70 years and older |
1962 and before 1952 and before |
23.4 % 36.2 % |
25.7 % 39.0 % |
- Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
- People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
- People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in the numerator. Therefore, these vaccination coverage figures are slightly lower than the actual totals.
The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. It is therefore not yet possible to provide a weekly update on participation in COVID-19 vaccination in the Netherlands.
4 October 2022 | 16:30
Vaccination figures for autumn round of COVID-19 repeat vaccination
From 19 September to 2 October 2022, more than 709,600 repeat vaccinations against COVID-19 were administered. Most of the repeat vaccinations administered last week were in the age group of 70 years and older. Vaccination coverage for the repeat vaccination among people over 70 has now reached 22.1%.
The repeat vaccination is now available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations were sent to people aged 60 years and older or turning 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.
Starting today, people aged 12 to 59 years who are eligible for the seasonal flu jab will receive an invitation from their GP. More information about COVID-19 vaccination, who will be invited and when is provided at Government.nl.
Table 1. Number of repeat vaccinations against COVID-19 in the autumn round, week 38 to week 39, 20221-3
Week | Cumulative number of repeat vaccinations against COVID-19 |
---|---|
38 | 261,535 |
39 | 709,622 |
- Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
- People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
- People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in these figures. Therefore, these figures are slightly lower than the actual total.
Table 2. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, week 38 to week 39, 2022 1-3
Age group | Birth years | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
60 years and older 70 years and older |
1962 and before 1952 and before |
13,3 % 22,1 % |
14,5 % 23,8 % |
- Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
- People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
- People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in the numerator. Therefore, these vaccination coverage figures are slightly lower than the actual totals.
The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. It is therefore not yet possible to provide a weekly update on participation in COVID-19 vaccination in the Netherlands.
27 September 2022 | 16:45
First vaccination figures for autumn round of COVID-19 repeat vaccination
From this week on, RIVM will start posting updates on vaccination figures for the autumn round of the repeat vaccination against COVID-19. The autumn round started last week, on 19 September 2022. Up to and including Sunday 25 September, more than 261,500 repeat vaccinations had been administered in the autumn round. Most of the repeat vaccinations administered last week were in the age group of 80 years and older. Vaccination coverage for the repeat vaccination among people over 80 has now reached 11.9%.
The repeat vaccination is available to everyone aged 12 years and older who has completed the basic series of COVID-19 vaccinations. The first invitations will be sent to people aged 60 years and older, people who will turn 60 this year, people in medical risk groups, and care workers who have contact with patients or clients. People can get the repeat vaccination starting from 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection.
As of today, people born in 1949 can make an appointment. More information about COVID-19 vaccination, who will be invited and when is provided at Government.nl.
Table 1. Number of repeat vaccinations against COVID-19 in the autumn round, week 38, 20221-3
Week | Cumulative number of repeat vaccinations against COVID-19 |
---|---|
38 | 261,535 |
- Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
- People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
- People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in these figures. Therefore, these figures are slightly lower than the actual total.
Table 2. Vaccination coverage for repeat vaccination against COVID-19 in the autumn round, week 38, 2022 1-3
Age group | Birth years | Vaccination coverage for repeat vaccination in autumn round, in relation to population of the Netherlands |
Vaccination coverage for repeat vaccination in autumn round, in relation to completed basic series |
---|---|---|---|
60 years and older 80 years and older |
1962 and before 1942 and before |
5,0 % 11,9 % |
5,9 % 15,6 % |
- Source: CoronIT (Municipal Public Health Services – GGD) and CIMS (general practitioners and other vaccinators)
- People who are eligible for a repeat vaccination against COVID-19 in the autumn round are over-60s, people under 60 who are invited for the seasonal flu vaccine every year, care workers and everyone over 12 who wants to get a repeat vaccination against COVID-19. Everyone must have completed their basic series of COVID-19 vaccinations before they are eligible for a repeat vaccination against COVID-19.
- People who are vaccinated by other vaccinators than the Municipal Public Health Services (GGDs) and have not given permission for registration in CIMS are not included in the numerator. Therefore, these vaccination coverage figures are slightly lower than the actual totals.
The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. It is therefore not yet possible to provide a weekly update on participation in COVID-19 vaccination in the Netherlands.
13 September 2022 | 15:55
Vaccination figures: 5 to 11 September 2022
The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. Data publication is expected to resume in 1 to 2 weeks.
6 September 2022 | 16:00
Vaccination figures: 29 August to 4 September 2022
Up to and including Sunday 4 September, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54,4%.
Numbers and vaccination coverage for COVID-19 booster vaccination
Almost 9.3 million booster jabs have been administered. 64% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.8% of all people over 18 years old have completed the basic series. 80.8% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 4 September 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 35 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 104,501 | 103,103 | 207,604 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 236,697 | 233,779 | 470,476 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 433,806 | 428,39 | 862,196 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 714,828 | 702,551 | 1,417,379 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 822,326 | 800,314 | 1,622,640 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 513,545 | 500,42 | 1,013,965 |
GGD | 60-64 | 1958-1962 | 495,266 | 486,792 | 982,058 | |
GGD | 55-59 | 1962-1967 | 27 April 2021 | 1,035,215 | 870,385 | 1,905,600 |
GGD | 50-54 | 1968-1972 | 20 May 2021 | 1,018,333 | 842,577 | 1,860,910 |
GGD | 45-49 | 1973-1977 | 26 May 2021 | 813,69 | 694,815 | 1,508,505 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 776,568 | 700,47 | 1,477,038 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 760,806 | 671,306 | 1,432,112 |
GGD | 30-34 | 1988-1992 | 7 June 2021 | 769,804 | 663,738 | 1,433,542 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 736,074 | 594,234 | 1,330,308 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,091,395 | 823,426 | 1,914,821 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 681,672 | 596,539 | 1,278,211 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 61,877 | 27,891 | 89,768 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,143,741 | 1,059,203 | 2,202,944 | ||
Other vaccinators (estimated) | 6 January 2021 | 640,81 | 471,099 | 1,111,909 | ||
Total | 12,850,959 | 11,271,036 | 24,121,995 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 35, 2022, by type of vaccinator.
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 35, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.7% | 80.8% |
18 years and older | 2004 and before | 83.5% | 82.8% |
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 35, 20221-4
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
30 August 2022 | 16:00
Vaccination figures: 22 to 28 August 2022
Up to and including Sunday 28 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54,2%. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM.
Numbers and vaccination coverage for COVID-19 booster vaccination
Almost 9.3 million booster jabs have been administered. 64% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.8% of all people over 18 years old have completed the basic series. 80.8% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 28 August 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 34 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 104,768 | 103,365 | 208,133 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 237,002 | 234,08 | 471,082 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 434,1 | 428,682 | 862,782 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 715,173 | 702,883 | 1,418,056 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 822,535 | 800,508 | 1,623,043 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 513,669 | 500,535 | 1,014,204 |
GGD | 60-64 | 1958-1962 | 495,34 | 486,864 | 982,204 | |
GGD | 55-59 | 1962-1967 | 27 April 2021 | 1,035,328 | 870,467 | 1,905,795 |
GGD | 50-54 | 1968-1972 | 20 May 2021 | 1,018,451 | 842,68 | 1,861,131 |
GGD | 45-49 | 1973-1977 | 26 May 2021 | 813,806 | 694,928 | 1,508,734 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 776,692 | 700,58 | 1,477,272 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 760,957 | 671,446 | 1,432,403 |
GGD | 30-34 | 1988-1992 | 7 June 2021 | 770,011 | 663,884 | 1,433,895 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 736,427 | 594,478 | 1,330,905 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,091,661 | 823,626 | 1,915,287 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 681,644 | 596,502 | 1,278,146 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 61,788 | 27,811 | 89,599 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,144,137 | 1,059,541 | 2,203,678 | ||
Other vaccinators (estimated) | 6 January 2021 | 641,368 | 471,628 | 1,112,996 | ||
Total | 12,854,862 | 11,274,492 | 24,129,354 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 34, 2022, by type of vaccinator.
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 34, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.7% | 80.8% |
18 years and older | 2004 and before | 83.6% | 82.8% |
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 34, 20221-4
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
23 August 2022 | 16:00
Vaccination figures: 15 to 21 August 2022
Up to and including Sunday 21 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54%. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM.
Numbers and vaccination coverage for COVID-19 booster vaccination
Almost 9.3 million booster jabs have been administered. 63.9% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.8% of all people over 18 years old have completed the basic series. 80.8% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 21 August 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 33 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 105,082 | 103,672 | 208,754 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 237,326 | 234,406 | 471,732 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 434,416 | 428,995 | 863,411 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 715,519 | 703,217 | 1,418,736 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 822,724 | 800,695 | 1,623,419 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 513,762 | 500,625 | 1,014,387 |
GGD | 60-64 | 1958-1962 | 495,384 | 486,91 | 982,294 | |
GGD | 55-59 | 1962-1967 | 27 April 2021 | 1,035,424 | 870,535 | 1,905,959 |
GGD | 50-54 | 1968-1972 | 20 May 2021 | 1,018,500 | 842,734 | 1,861,234 |
GGD | 45-49 | 1973-1977 | 26 May 2021 | 813,861 | 694,964 | 1,508,825 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 776,765 | 700,644 | 1,477,409 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 761,014 | 671,491 | 1,432,505 |
GGD | 30-34 | 1988-1992 | 7 June 2021 | 770,1 | 663,955 | 1,434,055 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 736,534 | 594,558 | 1,331,092 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,091,803 | 823,716 | 1,915,519 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 681,578 | 596,428 | 1,278,006 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 61,71 | 27,782 | 89,492 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,144,526 | 1,059,904 | 2,204,430 | ||
Other vaccinators (estimated) | 6 January 2021 | 641,923 | 472,165 | 1,114,088 | ||
Total | 12,857,956 | 11,277,400 | 24,135,356 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 33, 2022, by type of vaccinator.
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 33, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.7% | 80.8% |
18 years and older | 2004 and before | 83.6% | 82.8% |
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 33, 20221-4
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
16 August 2022 | 16:30
Vaccination figures: 8 to 14 August 2022
Up to and including Sunday 14 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 53.7%. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM.
Numbers and vaccination coverage for COVID-19 booster vaccination
Almost 9.3 million booster jabs have been administered. 63.9% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.8% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 14 August 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 32 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 105,385 | 103,973 | 209,358 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 237,605 | 234,681 | 472,286 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 434,715 | 429,288 | 864,003 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 715,798 | 703,488 | 1,419,286 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 822,933 | 800,892 | 1,623,825 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 513,853 | 500,713 | 1,014,566 |
GGD | 60-64 | 1958-1962 | 495,43 | 486,949 | 982,379 | |
GGD | 55-59 | 1962-1967 | 27 April 2021 | 1,035,499 | 870,589 | 1,906,088 |
GGD | 50-54 | 1968-1972 | 20 May 2021 | 1,018,556 | 842,778 | 1,861,334 |
GGD | 45-49 | 1973-1977 | 26 May 2021 | 813,927 | 695,014 | 1,508,941 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 776,834 | 700,695 | 1,477,529 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 761,052 | 671,52 | 1,432,572 |
GGD | 30-34 | 1988-1992 | 7 June 2021 | 770,168 | 663,988 | 1,434,156 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 736,64 | 594,615 | 1,331,255 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,091,956 | 823,807 | 1,915,763 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 681,498 | 596,359 | 1,277,857 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 61,597 | 27,715 | 89,312 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,144,881 | 1,060,238 | 2,205,119 | ||
Other vaccinators (estimated) | 6 January 2021 | 642,507 | 472,721 | 1,115,228 | ||
Total | 12,860,839 | 11,280,027 | 24,140,866 |
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 32, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.7% | 80.9% |
18 years and older | 2004 and before | 83.6% | 82.8% |
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
9 August 2022 | 16:00
Vaccination figures: 1 to 7 August 2022
Up to and including Sunday 7 August, almost 2.6 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 53.2%. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM.
Numbers and vaccination coverage for COVID-19 booster vaccination
Almost 9.3 million booster jabs have been administered. 63.9% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 7 August 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 31 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 105,617 | 104,204 | 209,821 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 237,938 | 235,009 | 472,947 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 435,03 | 429,594 | 864,624 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 716,096 | 703,778 | 1,419,874 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 823,099 | 801,056 | 1,624,155 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 513,949 | 500,807 | 1,014,756 |
GGD | 60-64 | 1958-1962 | 495,462 | 486,974 | 982,436 | |
GGD | 55-59 | 1962-1967 | 27 April 2021 | 1,035,571 | 870,64 | 1,906,211 |
GGD | 50-54 | 1968-1972 | 20 May 2021 | 1,018,629 | 842,83 | 1,861,459 |
GGD | 45-49 | 1973-1977 | 26 May 2021 | 814,011 | 695,071 | 1,509,082 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 776,931 | 700,792 | 1,477,723 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 761,121 | 671,597 | 1,432,718 |
GGD | 30-34 | 1988-1992 | 7 June 2021 | 770,25 | 664,048 | 1,434,298 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 736,759 | 594,68 | 1,331,439 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,092,069 | 823,86 | 1,915,929 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 681,441 | 596,3 | 1,277,741 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 61,544 | 27,677 | 89,221 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,145,169 | 1,060,490 | 2,205,659 | ||
Other vaccinators (estimated) | 6 January 2021 | 643,032 | 473,215 | 1,116,247 | ||
Total | 12,863,723 | 11,282,626 | 24,146,349 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 31, 2022, by type of vaccinator.
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 31, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.7% | 80.9% |
18 years and older | 2004 and before | 83.6% | 82.9% |
2 August 2022 | 16:00
Vaccination figures: 25 to 31 July 2022
Up to and including Sunday 31 July, almost 2.6 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 52.2%. Almost 70.000 repeat vaccinations have been administered in the past week. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM.
Numbers and vaccination coverage for COVID-19 booster vaccination
Almost 9.3 million booster jabs have been administered. 63.9% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab.
It is still possible to get a COVID-19 vaccination as a booster jab or repeat vaccination.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 31 July 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 30 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 105,924 | 104,501 | 210,425 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 238,277 | 235,345 | 473,622 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 435,343 | 429,903 | 865,246 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 716,386 | 704,058 | 1,420,444 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 823,307 | 801,264 | 1,624,571 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 514,048 | 500,902 | 1,014,950 |
GGD | 60-64 | 1958-1962 | 495,511 | 487,019 | 982,53 | |
GGD | 55-59 | 1962-1967 | 27 April 2021 | 1,035,701 | 870,734 | 1,906,435 |
GGD | 50-54 | 1968-1972 | 20 May 2021 | 1,018,720 | 842,896 | 1,861,616 |
GGD | 45-49 | 1973-1977 | 26 May 2021 | 814,106 | 695,141 | 1,509,247 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 777,054 | 700,91 | 1,477,964 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 761,302 | 671,727 | 1,433,029 |
GGD | 30-34 | 1988-1992 | 7 June 2021 | 770,383 | 664,136 | 1,434,519 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 736,934 | 594,75 | 1,331,684 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,092,287 | 823,963 | 1,916,250 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 681,371 | 596,179 | 1,277,550 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 61,451 | 27,628 | 89,079 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,145,539 | 1,060,815 | 2,206,354 | ||
Other vaccinators (estimated) | 6 January 2021 | 643,586 | 473,743 | 1,117,329 | ||
Total | 12,867,235 | 11,285,618 | 24,152,853 |
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 30, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.8% | 80.9% |
18 years and older | 2004 and before | 83.6% | 82.9% |
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
26 July 2022 | 16:15
Vaccination figures: 18 to 24 July 2022
Up to and including Sunday 24 July, more than 2.5 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 50.9%. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.2 million booster jabs have been administered. 63.8% of all people over 18 have received a booster jab. 59.2% of all people over 12 have received a booster jab.
It is still possible to get a COVID-19 vaccination as a booster jab or repeat vaccination.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 24 July 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 29 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 106,214 | 104,791 | 211,0015 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 238,632 | 235,692 | 474,324 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 435,678 | 430,230 | 865,908 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 716,680 | 704,337 | 1,624,988 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 823.518 | 801.470 | 1,625,404 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 514.152 | 501.003 | 1.015.155 |
GGD | 60-64 | 1958-1962 | 495.553 | 487.055 | 982.6908 | |
GGD | 55-59 | 1963-1967 | 27 April 2021 | 1,035,784 | 870,803 | 1,906,587 |
GGD | 50-54 | 1967-1972 | 20 May 2021 | 1,018,811 | 842,948 | 1,861,759 |
GGD | 44-49 | 1973-1977 | 26 May 2021 | 814,190 | 695,209 | 1,509,399 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 777,150 | 700,987 | 1,478,137 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 761,424 | 671,818 | 1,433,242 |
GGD | 30-34 | 1989-1992 | 7 June 2021 | 770,493 | 664,235 | 1,434,728 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 737,047 | 594,806 | 1,331,853 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,092,403 | 823,929 | 1,916,332 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 681,237 | 595,820 | 1,277,057 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 61,306 | 27,534 | 88,840 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,145,923 | 1,061,144 | 2,207,067 | ||
Other vaccinators (estimated) | 06 January 2021 | 644,154 | 474,252 | 1,118,406 | ||
Total | 12,870.354 | 11,288.067 | 24,158,421 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 26, 2022, by type of vaccinator.
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 29, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.8% | 80.9% |
18 years and older | 2004 and before | 83.7% | 82.9% |
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 26, 20221-4
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
19 July 2022 | 16:00
Vaccination figures: 11 to 17 July 2022
Up to and including Sunday 17 July, more than 2.4 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 49.3%. Over 100,000 repeat vaccinations were administered last week. This is the highest number of repeat vaccinations in one week within the past three months. The strongest increase was seen among people in their 70s and 80s. Those age groups received twice as many repeat vaccinations last week compared to the week before that. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.2 million booster jabs have been administered. 63.6% of all people over 18 have received a booster jab. 59.1% of all people over 12 have received a booster jab.
It is still possible to get a COVID-19 vaccination as a booster jab or repeat vaccination.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 17 July 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 28 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 106,516 | 105,085 | 211,601 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 238,946 | 235,996 | 474,942 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 436,006 | 430,551 | 866,557 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 716,983 | 704,638 | 1,421,621 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 823.726 | 801.678 | 1,625,404 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 514.231 | 501.084 | 1.015.315 |
GGD | 60-64 | 1958-1962 | 495.585 | 487.094 | 982.679 | |
GGD | 55-59 | 1963-1967 | 27 April 2021 | 1,035,849 | 870,857 | 1,906,706 |
GGD | 50-54 | 1967-1972 | 20 May 2021 | 1,018,874 | 842,984 | 1,861,858 |
GGD | 44-49 | 1973-1977 | 26 May 2021 | 814,247 | 695,232 | 1,509,479 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 777,236 | 701,053 | 1,478,289 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 761,504 | 671,874 | 1,433,378 |
GGD | 30-34 | 1989-1992 | 7 June 2021 | 770,551 | 664,274 | 1,434,825 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 737,105 | 594,834 | 1,331,939 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,092,450 | 823,876 | 1,916,326 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 680,973 | 595,289 | 1,276.262 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 61,093 | 27,397 | 88,490 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,146,333 | 1,061,539 | 2,207,872 | ||
Other vaccinators (estimated) | 06 January 2021 | 644,723 | 474,749 | 1,119,472 | ||
Total | 12,872.936 | 11,290.088 | 24,163,024 |
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 28, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.8% | 80.9% |
18 years and older | 2004 and before | 83.7% | 82.9% |
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
12 July 2022 | 16:00
Vaccination figures: 4 to 10 July 2022
Up to and including Sunday 10 July, more than 2.3 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 47.3%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.2 million booster jabs have been administered. 63.6% of all people over 18 have received a booster jab. 59.1% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 82.9% of all people over 18 years old have completed the basic series. 80.9% of all people over 12 years old have completed the basic series.
It is still possible to get a COVID-19 vaccination as part of the basic series, as a booster jab or as a repeat vaccination.
Incorporating the latest population data
Once every quarter, the latest population data is incorporated into the weekly updates. The current population data for July 2022 were used in this weekly update. The age groups have also been adjusted, and the formula used to calculate age has been updated to 2022 minus year of birth. Vaccination coverage is slightly lower after these adjustments. Vaccination coverage for the basic series is down by 1% following the adjustments.
Vaccination figures: 6 January 2021 – 10 July 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 26 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 90+ | 1932 and earlier | 26 January 2021 | 106,784 | 105,346 | 212,130 |
GGD | 85-89 | 1933-1937 | 29 January 2021 | 239,257 | 236,307 | 475,564 |
GGD | 80-84 | 1938-1942 | 5 February 2021 | 436,315 | 430,851 | 867,166 |
GGD | 75-79 | 1943-1947 | 6 March 2021 | 717,247 | 704,904 | 1,422,151 |
GGD | 70-74 | 1948-1952 | 6 April 2021 | 823,930 | 801,867 | 1,625,797 |
GGD | 65-69 | 1953-1957 | 19 April 2021 | 514,329 | 501,177 | 1,015,506 |
GGD | 60-64 | 1958-1962 | 495,627 | 487,130 | 982,757 | |
GGD | 55-59 | 1963-1967 | 27 April 2021 | 1,035,911 | 870,899 | 1,906,810 |
GGD | 50-54 | 1967-1972 | 20 May 2021 | 1,018,939 | 843,012 | 1,861,951 |
GGD | 44-49 | 1973-1977 | 26 May 2021 | 814,315 | 695,285 | 1,509,600 |
GGD | 40-44 | 1978-1982 | 29 May 2021 | 777,314 | 701,100 | 1,478,414 |
GGD | 35-39 | 1983-1987 | 1 June 2021 | 761,569 | 671,915 | 1,433,484 |
GGD | 30-34 | 1989-1992 | 7 June 2021 | 770,563 | 664,253 | 1,434,816 |
GGD | 25-29 | 1993-1997 | 11 June 2021 | 737,136 | 594,826 | 1,331,962 |
GGD | 18-24 | 1998-2004 | 15 June 2021 | 1,092,519 | 823,729 | 1,916,248 |
GGD | 12-17 | 2005-2010 | 22 June 2021 | 680,524 | 594,451 | 1,274,975 |
GGD | 5-11 | 2011-2017 | 18 January 2022 | 60,750 | 27,211 | 87,961 |
GGD | Unknown | Unknown | 5 | 4 | 9 | |
GPs (estimated) | 15 February 2021 | 1,146,699 | 1,061,864 | 2,208,563 | ||
Other vaccinators (estimated) | 06 January 2021 | 645,267 | 475,276 | 1,120,543 | ||
Total | 12,875,000 | 11,291,407 | 24,155,407 |
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 27, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2010 and before | 81.8% | 80.9% |
18 years and older | 2004 and before | 83.7% | 82.9% |
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
5 July 2022 | 16:00
Vaccination figures: 27 June – 3 July 2022
Up to and including Sunday 3 July, more than 2.2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 47.1%. For the past 3 weeks, the weekly number of repeat vaccinations has been increasing. More than twice as many repeat vaccinations were administered last week compared to the week of 6 June. The strongest increase was seen among people aged 60-69 years.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.2 million booster jabs have been administered. 64.3% of all people over 18 have received a booster jab. 59.7% of all people over 12 have received a booster jab. The weekly number of booster jabs has been increasing for 3 weeks now. Nearly twice as many booster jabs were administered last week compared to the week of 6 June. The strongest increase was seen among people aged 12-25 years.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 83.1% of all people over 18 years old have completed the basic series. 81.9% of all people over 12 years old have completed the basic series.
It is still possible to get a COVID-19 vaccination as part of the basic series, as a booster jab or as a repeat vaccination.
Vaccination figures: 6 January 2021 – 3 July 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 26 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 56,772 | 55,976 | 112,748 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 172,377 | 170,247 | 342,624 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 359,918 | 355,466 | 715,384 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 558,881 | 550,797 | 1,109,678 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 848,654 | 829,206 | 1,677,860 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 795,224 | 771,059 | 1,566,283 |
GGD | 61-65 | 1956-1960 | 145,349 | 159,632 | 304,981 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,024,958 | 965,69 | 1,990,648 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,037,850 | 767,082 | 1,804,932 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 891,264 | 815,721 | 1,706,985 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 783,168 | 662,58 | 1,445,748 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 759,721 | 676,317 | 1,436,038 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 771,026 | 672,84 | 1,443,866 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 754,806 | 629,928 | 1,384,734 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,233,179 | 919,153 | 2,152,332 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 800,163 | 711,678 | 1,511,841 |
GGD | 5-11 | 2010-2016 | 18 January 2022 | 87,869 | 39,386 | 127,255 |
GGD | Unknown | Unknown | 1,418 | 759 | 2,177 | |
GPs (estimated) | 15 February 2021 | 1,147,110 | 1,062,154 | 2,209,264 | ||
Other vaccinators (estimated) | 6 January 2021 | 645,718 | 475,77 | 1,121,488 | ||
Total | 12,875,425 | 11,291,441 | 24,166,866 |
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 26, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 82,7% | 81,9% |
18 years and older | 2003 and before | 83,9% | 83,1% |
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
28 June 2022 | 16:30
Vaccination figures: 20 June – 26 June 2022
Up to and including Sunday 26 June 2022, more than 2.2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 45.7%. For the past two weeks, the weekly number of repeat vaccinations has been increasing. 59% more repeat vaccinations were administered last week compared to the week of 6 June. The strongest increase was seen in the age group of people aged 60 to 70 years.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered. 64.2% of all people over 18 have received a booster jab. 59.6% of all people over 12 have received a booster jab. Since last week, the weekly number of booster jabs has also been increasing. 31% more booster jabs were administered last week compared to the week of 13 June. The strongest increase was seen in the age group of young people aged 12 to 19 years.
Everyone who has been invited to get a booster jab or repeat vaccination against COVID-19, but has not yet done so, can still get the jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 83.1% of all people over 18 years old have completed the basic series. 81.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 26 June 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 25 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 56,953 | 56,152 | 113,105 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 172,677 | 170,541 | 343,218 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 360,259 | 355,803 | 716,062 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 559,197 | 551,109 | 1,110,306 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 848,931 | 829,482 | 1,678,413 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 795,397 | 771,234 | 1,566,631 |
GGD | 61-65 | 1956-1960 | 145,365 | 159,643 | 305,008 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,025,076 | 965,799 | 1,990,875 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,037,926 | 767,124 | 1,805,050 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 891,326 | 815,756 | 1,707,082 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 783,236 | 662,61 | 1,445,846 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 759,797 | 676,349 | 1,436,146 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 771,165 | 672,933 | 1,444,098 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 754,897 | 629,943 | 1,384,840 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,233,303 | 919,034 | 2,152,337 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 799,969 | 711,144 | 1,511,113 |
GGD | 5-11 | 2010-2016 | 18 January 2022 | 86,841 | 38,592 | 125,433 |
GGD | Unknown | Unknown | 1,378 | 739 | 2,117 | |
GPs (estimated) | 15 February 2021 | 1,147,479 | 1,062,490 | 2,209,969 | ||
Other vaccinators (estimated) | 6 January 2021 | 646,282 | 476,295 | 1,122,577 | ||
Total | 12,877,454 | 11,292,772 | 24,170,226 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 25, 2022, by type of vaccinator.
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 25, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 82,8% | 81,9% |
18 years and older | 2003 and before | 83,9% | 83,1% |
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 25, 20221-4
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
21 June 2022 | 16:00
Vaccination figures: 13 June – 19 June 2022
Up to and including Sunday 19 June 2022, more than 2.1 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 44.2%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered. 64.1% of all people over 18 have received a booster jab. 59.5% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 83.2% of all people over 18 years old have completed the basic series. 81.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 19 June 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 24 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 57,146 | 56,34 | 113,486 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 172,968 | 170,824 | 343,792 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 360,598 | 356,133 | 716,731 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 559,493 | 551,405 | 1,110,898 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 849,164 | 829,717 | 1,678,881 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 795,548 | 771,379 | 1,566,927 |
GGD | 61-65 | 1956-1960 | 145,34 | 159,627 | 304,967 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,025,114 | 965,823 | 1,990,937 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,037,948 | 767,119 | 1,805,067 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 891,344 | 815,724 | 1,707,068 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 783,254 | 662,591 | 1,445,845 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 759,85 | 676,34 | 1,436,190 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 771,188 | 672,926 | 1,444,114 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 754,881 | 629,885 | 1,384,766 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,233,269 | 918,791 | 2,152,060 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 799,725 | 710,57 | 1,510,295 |
GGD | 5-11 | 2010-2016 | 18 January 2022 | 85,599 | 37,772 | 123,371 |
GGD | Unknown | Unknown | 1,469 | 853 | 2,322 | |
GPs (estimated) | 15 February 2021 | 1,147,803 | 1,062,781 | 2,210,584 | ||
Other vaccinators (estimated) | 6 January 2021 | 646,837 | 476,804 | 1,123,641 | ||
Total | 12,878,538 | 11,293,404 | 24,171,942 |
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 24, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 82,8% | 81,9% |
18 years and older | 2003 and before | 83,9% | 83,2% |
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
14 June 2022 | 16:00
Vaccination figures: 6 June – 12 June 2022
Up to and including Sunday 12 June 2022, more than 2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 43.1%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered. 64.1% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 81.9% of all people over 18 years old have completed the basic series. 83.2% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 12 June 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 23 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 57,299 | 56,49 | 113,789 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 173,264 | 171,109 | 344,373 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 360,899 | 356,428 | 717,327 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 559,782 | 551,688 | 1,111,470 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 849,429 | 829,976 | 1,679,405 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 795,697 | 771,516 | 1,567,213 |
GGD | 61-65 | 1956-1960 | 145,341 | 159,631 | 304,972 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,025,178 | 965,871 | 1,991,049 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,038,017 | 767,145 | 1,805,162 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 891,388 | 815,722 | 1,707,110 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 783,271 | 662,584 | 1,445,855 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 759,866 | 676,338 | 1,436,204 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 771,232 | 672,937 | 1,444,169 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 754,907 | 629,883 | 1,384,790 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,233,187 | 918,59 | 2,151,777 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 799,512 | 710,157 | 1,509,669 |
GGD | 5-11 | 2010-2016 | 18 January 2022 | 84,683 | 37,062 | 121,745 |
GGD | Unknown | Unknown | 1,426 | 832 | 2,258 | |
GPs (estimated) | 15 February 2021 | 1,148,176 | 1,063,113 | 2,211,289 | ||
Other vaccinators (estimated) | 6 January 2021 | 647,429 | 477,358 | 1,124,787 | ||
Total | 12,879,983 | 11,294,430 | 24,174,413 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 23, 2022, by type of vaccinator.
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 23, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 82,8% | 81,9% |
18 years and older | 2003 and before | 83,9% | 83,2% |
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 23, 20221-4
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
7 June 2022 | 16:00
Vaccination figures: 30 May – 5 June 2022
Up to and including Sunday 5 June 2022, more than 2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 42.5%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered. 64% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 81.9% of all people over 18 years old have completed the basic series. 83.2% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 5 June 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 22 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 57,467 | 56,657 | 114,124 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 173,537 | 171,372 | 344,909 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 361,185 | 356,709 | 717,894 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 560,058 | 551,950 | 1,112,008 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 849,689 | 830,229 | 1,679,918 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 795,838 | 771,644 | 1,567,482 |
GGD | 61-65 | 1956-1960 | 145,351 | 159,643 | 304,994 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,025,259 | 965,946 | 1,991,205 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,038,072 | 767,184 | 1,805,256 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 891,404 | 815,724 | 1,707,128 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 783,277 | 662,574 | 1,445,851 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 759,897 | 676,320 | 1,436,217 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 771,245 | 672,908 | 1,444,153 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 754,923 | 629,856 | 1,384,779 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,233,123 | 918,446 | 2,151,569 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 799,323 | 709,854 | 1,509,177 |
GGD | 5-11 | 2010-2016 | 18 January 2022 | 84,005 | 36,541 | 120,546 |
GGD | Unknown | Unknown | 1,391 | 819 | 2,210 | |
GPs (estimated) | 15 February 2021 | 1,148,565 | 1,063,466 | 2,212,031 | ||
Other vaccinators (estimated) | 6 January 2021 | 647,937 | 477,829 | 1,125,766 | ||
Total | 12,881,546 | 11,295,671 | 24,177,217 |
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 22, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 82,8% | 81,9% |
18 years and older | 2003 and before | 84,0% | 83,2% |
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
31 May 2022 | 16:00
Vaccination figures: 23 to 29 May 2022
Up to and including Sunday 29 May, more than 2 million repeat vaccinations had been administered in the Netherlands. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 41.8%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered. 64% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
More than 24 million first and second vaccinations in the basic series of vaccinations have been administered. 83.2% of all people over 18 years old have completed the basic series. 82% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 29 May 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 21 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 57,662 | 56,849 | 114,511 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 173,876 | 171,705 | 345,581 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 361,543 | 357,059 | 718,602 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 560,39 | 552,274 | 1,112,664 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 850,014 | 830,541 | 1,680,555 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 796,052 | 771,84 | 1,567,892 |
GGD | 61-65 | 1956-1960 | 145,366 | 159,649 | 305,015 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,025,363 | 966,036 | 1,991,399 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,038,135 | 767,216 | 1,805,351 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 891,485 | 815,769 | 1,707,254 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 783,325 | 662,592 | 1,445,917 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 759,986 | 676,381 | 1,436,367 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 771,376 | 672,981 | 1,444,357 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 755,064 | 629,947 | 1,385,011 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,233,099 | 918,266 | 2,151,365 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 799,075 | 709,578 | 1,508,653 |
GGD | 5-11 | 2010-2016 | 18 January 2022 | 83,126 | 36,05 | 119,176 |
GGD | Unknown | Unknown | 1,362 | 809 | 2,171 | |
GPs (estimated) | 15 February 2021 | 1,148,956 | 1,063,847 | 2,212,803 | ||
Other vaccinators (estimated) | 6 January 2021 | 648,602 | 478,437 | 1,127,039 | ||
Total | 12,883,857 | 11,297,826 | 24,181,683 |
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 21, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.8% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
24 May 2022 | 15:15
COVID-19 vaccination figures more up-to-date due to optimised monitoring
RIVM has been publishing national and regional figures on COVID-19 vaccination in the Netherlands every week since 19 January 2021. As of 24 May 2022, the method used to monitor vaccination figures has been optimised and population data has been updated. As a result, the figures provide a more up-to-date and accurate overview of vaccination coverage in the Dutch population. The optimisation process has resulted in adjusted vaccination coverage figures
Read the news: COVID-19 vaccination figures more up-to-date due to optimised monitoring
Vaccination figures: 6 January 2021 – 22 May 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 20 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 57,808 | 56,994 | 114,802 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 174,11 | 171,931 | 346,041 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 361,824 | 357,335 | 719,159 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 560,632 | 552,514 | 1,113,146 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 850,239 | 830,761 | 1,681,000 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 796,165 | 771,949 | 1,568,114 |
GGD | 61-65 | 1956-1960 | 145,377 | 159,646 | 305,023 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,025,436 | 966,112 | 1,991,548 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,038,152 | 767,223 | 1,805,375 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 891,495 | 815,767 | 1,707,262 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 783,327 | 662,572 | 1,445,899 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 759,989 | 676,378 | 1,436,367 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 771,383 | 672,978 | 1,444,361 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 755,058 | 629,929 | 1,384,987 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,232,990 | 918,114 | 2,151,104 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 798,812 | 709,291 | 1,508,103 |
GGD | 5-11 | 2010-2016 | 18 January 2022 | 82,092 | 35,521 | 117,613 |
GGD | Unknown | Unknown | 1,341 | 798 | 2,139 | |
GPs (estimated) | 15 February 2021 | 1,149,244 | 1,064,132 | 2,213,376 | ||
Other vaccinators (estimated) | 6 January 2021 | 649,128 | 478,922 | 1,128,050 | ||
Total | 12,884,602 | 11,298,867 | 24,183,469 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 20, 2022, by type of vaccinator.
- Source: CIMS/CoronIT (GGD) and CIMS+ (GPs and Other vaccinators)
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to 20, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.8% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout for at least one dose and vaccination coverage for the basic series of COVID-19 vaccination, week 1, 2021 to week 20, 20221-4
- Source: CIMS+ methode
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- People in the ‘age unknown’ group are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group. The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on CIMS/CoronIT are displayed in Figures 1 and 2 of this report. Due to the factor listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series for the 12-17 age group by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
17 May 2022 | 16:15
Vaccination figures: 9 to 15 May 2022
Up to and including Sunday 15 May, more than 1.9 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 39.9%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.2 million booster jabs have been administered. 64.2% of all people over 18 have received a booster jab. 59.5% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 15 May 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 19 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,804 | 67,268 | 136,072 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,456 | 187,581 | 378,037 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,299 | 374,543 | 753,842 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,178 | 568,161 | 1,144,339 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 864,03 | 844,617 | 1,708,647 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,884 | 780,892 | 1,586,776 |
GGD | 61-65 | 1956-1960 | 150,216 | 164,226 | 314,442 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,764 | 976,533 | 2,013,297 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,050,188 | 777,001 | 1,827,189 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,836 | 826,366 | 1,730,202 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 796,281 | 673,513 | 1,469,794 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,661 | 689,701 | 1,464,362 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 788,598 | 688,965 | 1,477,563 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 775,15 | 648,505 | 1,423,655 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,255,197 | 940,844 | 2,196,041 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 804,725 | 724,281 | 1,529,006 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 81,585 | 35,095 | 116,68 |
GGD | Unknown | Unknown | 4,211 | 3,094 | 7,305 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,472,817 | 11,542,904 | 25,015,721 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 19, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,788 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 19, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.8% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 19, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group.
The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
11 May 2022 | 8:30
Vaccination figures: 2 to 8 May 2022
Up to and including Sunday 8 May, more than 1.8 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 38.9%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered by now. 64.2% of all people over 18 have received a booster jab. 59.4% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 8 May 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 18 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,803 | 67,267 | 136,07 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,454 | 187,578 | 378,032 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,292 | 374,535 | 753,827 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,169 | 568,148 | 1,144,317 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 864,015 | 844,599 | 1,708,614 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,865 | 780,876 | 1,586,741 |
GGD | 61-65 | 1956-1960 | 150,193 | 164,191 | 314,384 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,727 | 976,498 | 2,013,225 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,050,150 | 776,968 | 1,827,118 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,801 | 826,309 | 1,730,110 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 796,238 | 673,454 | 1,469,692 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,596 | 689,619 | 1,464,215 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 788,507 | 688,873 | 1,477,380 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 775,04 | 648,373 | 1,423,413 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,255,001 | 940,616 | 2,195,617 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 804,483 | 724,082 | 1,528,565 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 80,7 | 34,627 | 115,327 |
GGD | Unknown | Unknown | 4,204 | 3,105 | 7,309 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,470,992 | 11,541,436 | 25,012,428 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 18, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,720 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 18, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.8% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 18, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group.
The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
03 May 2022 | 16:00
Vaccination figures: 25 April to 1 May 2022
Up to and including Sunday 1 May, more than 1.8 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 37.7%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered by now. 64% of all people over 18 have received a booster jab. 59.3% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 1 May 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 17 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,803 | 67,266 | 136,069 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,453 | 187,576 | 378,029 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,29 | 374,531 | 753,821 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,156 | 568,134 | 1,144,290 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,999 | 844,585 | 1,708,584 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,844 | 780,856 | 1,586,700 |
GGD | 61-65 | 1956-1960 | 150,17 | 164,162 | 314,332 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,703 | 976,465 | 2,013,168 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,050,125 | 776,922 | 1,827,047 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,766 | 826,268 | 1,730,034 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 796,192 | 673,399 | 1,469,591 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,526 | 689,548 | 1,464,074 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 788,433 | 688,777 | 1,477,210 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,952 | 648,242 | 1,423,194 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,254,804 | 940,36 | 2,195,164 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 804,272 | 723,76 | 1,528,032 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 79,73 | 34,124 | 113,854 |
GGD | Unknown | Unknown | 4,195 | 3,103 | 7,298 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,469,167 | 11,539,796 | 25,008,963 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 17, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,647 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 17, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.8% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 17, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC). In addition, as of 28 April 2022, the ECDC uses different denominator data to calculate turnout and vaccination coverage for the basic series of COVID-19 vaccinations than the denominator used by RIVM.
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group.
The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
26 April 2022 | 16:00
Vaccination figures 18-24 April 2022
Up to and including Sunday 24 April, more than 1.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 35.8%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered by now. 63.9% of all people over 18 have received a booster jab. 59.2% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 24 April 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 16 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,803 | 67,265 | 136,068 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,453 | 187,576 | 378,029 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,286 | 374,527 | 753,813 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,15 | 568,123 | 1,144,273 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,985 | 844,566 | 1,708,551 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,824 | 780,842 | 1,586,666 |
GGD | 61-65 | 1956-1960 | 150,144 | 164,133 | 314,277 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,678 | 976,426 | 2,013,104 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,050,093 | 776,861 | 1,826,954 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,743 | 826,22 | 1,729,963 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 796,154 | 673,348 | 1,469,502 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,481 | 689,48 | 1,463,961 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 788,36 | 688,674 | 1,477,034 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,863 | 648,121 | 1,422,984 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,254,649 | 940,14 | 2,194,789 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 804,039 | 723,483 | 1,527,522 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 79,077 | 33,65 | 112,727 |
GGD | Unknown | Unknown | 4,202 | 3,103 | 7,305 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,467,738 | 11,538,256 | 25,005,994 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 15, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,588 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 16, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.8% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 15, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group.
The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
19 April 2022 | 16:00
Vaccination figures 11-17 April 2022
Up to and including Sunday 17 April, more than 1.5 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has reached 32.7%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered by now. 63.8% of all people over 18 have received a booster jab. 59.1% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
It is estimated that 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 17 April 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 15 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,801 | 67,261 | 136,062 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,45 | 187,571 | 378,021 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,281 | 374,522 | 753,803 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,143 | 568,116 | 1,144,259 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,975 | 844,545 | 1,708,520 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,802 | 780,811 | 1,586,613 |
GGD | 61-65 | 1956-1960 | 150,114 | 164,099 | 314,213 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,657 | 976,389 | 2,013,046 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,050,062 | 776,819 | 1,826,881 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,701 | 826,166 | 1,729,867 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 796,124 | 673,289 | 1,469,413 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,43 | 689,407 | 1,463,837 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 788,285 | 688,552 | 1,476,837 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,783 | 647,987 | 1,422,770 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,254,462 | 939,864 | 2,194,326 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 803,86 | 723,164 | 1,527,024 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 78,252 | 32,553 | 110,805 |
GGD | Unknown | Unknown | 4,205 | 3,098 | 7,303 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,466,141 | 11,535,931 | 25,002,072 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 15, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,533 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 15, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 15, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group.
The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
12 April 2022 | 16:00
Vaccination figures 4-10 April 2022
Up to and including Sunday 10 April, more than 1.3 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has reached 28.5%.
Numbers and vaccination coverage for COVID-19 booster vaccination
More than 9.1 million booster jabs have been administered by now. 63.6% of all people over 18 have received a booster jab. 58.9% of all people over 12 have received a booster jab.
Numbers and vaccination coverage for basic series of COVID-19 vaccinations
It is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 10 April 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 14 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,801 | 67,261 | 136,062 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,448 | 187,566 | 378,014 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,277 | 374,518 | 753,795 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,131 | 568,103 | 1,144,234 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,962 | 844,524 | 1,708,486 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,775 | 780,781 | 1,586,556 |
GGD | 61-65 | 1956-1960 | 150,079 | 164,07 | 314,149 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,624 | 976,347 | 2,012,971 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,050,032 | 776,751 | 1,826,783 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,663 | 826,09 | 1,729,753 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 796,067 | 673,2 | 1,469,267 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,378 | 689,295 | 1,463,673 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 788,19 | 688,41 | 1,476,600 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,685 | 647,838 | 1,422,523 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,254,300 | 939,561 | 2,193,861 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 803,681 | 722,755 | 1,526,436 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 77,466 | 30,899 | 108,365 |
GGD | Unknown | Unknown | 4,222 | 3,098 | 7,32 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,464,535 | 11,532,785 | 24,997,320 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 14, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,453 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 14, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 14, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group.
The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
5 April 2022 | 16:00
Vaccination figures: 28 March to 3 April 2022
Up to and including Sunday 3 April, more than 1 million repeat vaccinations had been administered in the Netherlands. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19. They can get the repeat vaccination 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. As of this week, this report also includes vaccination coverage and the graph by age for the repeat vaccination against COVID-19. Vaccination coverage for the repeat vaccination among people over 60 has reached 22.4%.
Numbers and vaccination coverage for the booster vaccination
More than 9 million booster vaccinations have been given by now. 63.4% of all people over 18 have received a booster vaccination. 58.7% of all people over 12 have received a booster vaccination.
Numbers and vaccination coverage for the basic series
It is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations have been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity. It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Vaccination figures: 6 January 2021 – 3 April 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 13 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,799 | 67,257 | 136,056 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,447 | 187,563 | 378,01 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,268 | 374,508 | 753,776 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,117 | 568,084 | 1,144,201 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,942 | 844,481 | 1,708,423 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,756 | 780,744 | 1,586,500 |
GGD | 61-65 | 1956-1960 | 150,058 | 164,01 | 314,068 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,596 | 976,278 | 2,012,874 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,049,983 | 776,679 | 1,826,662 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,625 | 826,003 | 1,729,628 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 796,008 | 673,098 | 1,469,106 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,315 | 689,159 | 1,463,474 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 788,103 | 688,25 | 1,476,353 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,587 | 647,641 | 1,422,228 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,254,101 | 939,191 | 2,193,292 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 803,502 | 722,202 | 1,525,704 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 76,777 | 27,476 | 104,253 |
GGD | Unknown | Unknown | 4,231 | 3,085 | 7,316 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,462,969 | 11,527,427 | 24,990,396 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 13, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,380 vaccinations (data up to 31 March 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,401 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 13, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 13, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout for at least one dose and vaccination coverage for the basic series for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older. The category of people aged 18 years and older does not include this entire group.
The turnout for at least one dose and vaccination coverage for the basic series for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout for at least one dose and vaccination coverage for the basic series by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
29 March 2022 | 16:15
Vaccination figures 21 to 27 March 2022
As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. As of 26 March, this option is available to people aged 60 years and older. Up to and including Sunday 27 March, more than 725,000 repeat vaccinations had been administered.
Numbers and vaccination coverage for the basic series
By Sunday 27 March 2022, it is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.
It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Numbers and vaccination coverage for the booster vaccination
By now, more than 8.9 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.
62.8% of all people over 18 have received a booster vaccination. 58.1% of all people over 12 have received a booster vaccination.
Vaccination figures: 6 January 2021 – 27 March 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 12 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,795 | 67,252 | 136,047 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,443 | 187,558 | 378,001 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,257 | 374,49 | 753,747 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,092 | 568,06 | 1,144,152 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,912 | 844,453 | 1,708,365 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,728 | 780,711 | 1,586,439 |
GGD | 61-65 | 1956-1960 | 150,03 | 163,97 | 314 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,553 | 976,232 | 2,012,785 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,049,938 | 776,625 | 1,826,563 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,599 | 825,935 | 1,729,534 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 795,971 | 673,008 | 1,468,979 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,253 | 689,06 | 1,463,313 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 788,013 | 688,101 | 1,476,114 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,495 | 647,451 | 1,421,946 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,253,925 | 938,863 | 2,192,788 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 803,544 | 721,807 | 1,525,351 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 76,093 | 19,469 | 95,562 |
GGD | Unknown | Unknown | 4,469 | 3,207 | 7,676 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,461,864 | 11,517,970 | 24,979,834 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 12, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,355 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 12, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 12, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 5 and 6 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
22 March 2022 | 16:30
Vaccination figures 14 to 20 March 2022
As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. Up to and including Sunday 20 March, 429,000 repeat vaccinations had been administered.
Numbers and vaccination coverage for the basic series
By Sunday 20 March 2022, it is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.
It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Numbers and vaccination coverage for the booster vaccination
By now, more than 8.9 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.
62.6% of all people over 18 have received a booster vaccination. 57.9% of all people over 12 have received a booster vaccination.
Vaccination figures: 6 January 2021 – 20 March 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 11 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,794 | 67,248 | 136,042 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,441 | 187,553 | 377,994 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,251 | 374,485 | 753,736 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,076 | 568,039 | 1,144,115 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,892 | 844,423 | 1,708,315 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,699 | 780,672 | 1,586,371 |
GGD | 61-65 | 1956-1960 | 149,983 | 163,934 | 313,917 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,498 | 976,177 | 2,012,675 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,049,885 | 776,552 | 1,826,437 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,54 | 825,856 | 1,729,396 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 795,903 | 672,893 | 1,468,796 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,146 | 688,914 | 1,463,060 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 787,873 | 687,896 | 1,475,769 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,364 | 647,22 | 1,421,584 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,253,741 | 938,512 | 2,192,253 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 803,368 | 721,416 | 1,524,784 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 75,052 | 4,467 | 79,519 |
GGD | Unknown | Unknown | 4,476 | 3,199 | 7,675 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,459,736 | 11,501,174 | 24,960,910 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,302 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 11, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
15 March 2022 | 16:50
Vaccination figures 7 March to 13 March 2022
As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. Up to and including Sunday 13 March, 178,300 repeat vaccinations had been administered.
Numbers and vaccination coverage for the basic series
By Sunday 13 March 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.
It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Numbers and vaccination coverage for the booster vaccination
By now, more than 8.9 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.
62.4% of all people over 18 have received a booster vaccination. As of last week, young people aged 12-18 years can also get a booster vaccination. 57.7% of all people over 12 have received a booster vaccination.
Vaccination figures: 6 January 2021 – 13 March 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 10 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,789 | 67,244 | 136,033 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,433 | 187,544 | 377,977 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,238 | 374,469 | 753,707 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,053 | 568,024 | 1,144,077 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,852 | 844,398 | 1,708,250 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,652 | 780,637 | 1,586,289 |
GGD | 61-65 | 1956-1960 | 149,908 | 163,893 | 313,801 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,426 | 976,097 | 2,012,523 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,049,814 | 776,466 | 1,826,280 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,455 | 825,763 | 1,729,218 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 795,827 | 672,809 | 1,468,636 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 774,037 | 688,76 | 1,462,797 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 787,735 | 687,684 | 1,475,419 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,203 | 646,963 | 1,421,166 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,253,523 | 938,126 | 2,191,649 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 803,182 | 721,117 | 1,524,299 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 74,402 | 1,057 | 75,459 |
GGD | Unknown | Unknown | 4,527 | 3,251 | 7,778 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,457,810 | 11,496,020 | 24,953,830 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,258 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 10, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
8 March 2022 | 16:30
Vaccination figures 28 February 2022 to 6 March 2022
Numbers and vaccination coverage for the basic series
By Sunday 6 March 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.
It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.
Numbers and vaccination coverage for the booster vaccination
By now, more than 8.8 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.
62.0% of all people over 18 have now received a booster vaccination.
Vaccination figures: 6 January 2021 – 6 March 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 9 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,788 | 67,236 | 136,024 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,430 | 187,531 | 377,961 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,221 | 374,441 | 753,662 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,032 | 567.988 | 1,144,020 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,821 | 844,341 | 1,708,162 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,629 | 780,595 | 1,586,223 |
GGD | 61-65 | 1956-1960 | 149,876 | 163,832 | 313,708 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,389 | 976,031 | 2,012,420 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,049,762 | 776,378 | 1,826,140 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,415 | 825,641 | 1,729,056 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 795,782 | 672,695 | 1,468,477 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 773,952 | 688,573 | 1,462,525 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 787,626 | 687,454 | 1,475,080 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 774,063 | 646,627 | 1,420,690 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,253,314 | 937,628 | 2,190,942 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 803,003 | 720,750 | 1,523,753 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 73,803 | 925 | 74,728 |
GGD | Unknown | Unknown | 4,590 | 3,319 | 7,909 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,456,250 | 11,493,702 | 24,949,952 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week 8, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,147 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 9, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 9, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
1 March 2022 | 16:00
Vaccination figures 21 to 27 February 2021
Number of vaccinations in the basic series
By Sunday 27 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. About 13.5 million of those were first vaccinations, and nearly 11.5 million were second vaccinations. More than 133,000 third vaccinations were administered to people with severely impaired immunity.
Vaccination coverage for the basic series
It is estimated that 89.4% of all people over 18 have received at least one vaccination in the basic series, and 86.4% have completed the basic series. According to estimates, 87.7% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.9% have completed the basic series.
Number of booster vaccinations
By now, more than 8.8 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.
Vaccination coverage for the booster vaccination
61.9% of all people over 18 have now received a booster vaccination.
Vaccination figures: 6 January 2021 – 27 February 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 8 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total4 |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,783 | 67,226 | 136,009 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,424 | 187,521 | 377,945 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,212 | 374,416 | 753,628 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,022 | 567,958 | 1,143,980 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,804 | 844,305 | 1,708,109 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,59 | 780,542 | 1,586,132 |
GGD | 61-65 | 1956-1960 | 149,842 | 163,754 | 313,596 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,346 | 975,921 | 2,012,267 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,049,708 | 776,236 | 1,825,944 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,351 | 825,5 | 1,728,851 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 795,682 | 672,524 | 1,468,206 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 773,841 | 688,301 | 1,462,142 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 787,461 | 687,086 | 1,474,547 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 773,861 | 646,179 | 1,420,040 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,253,031 | 936,973 | 2,190,004 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 802,766 | 720,202 | 1,522,968 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 72,955 | 752 | 73,707 |
GGD | Unknown | Unknown | 4,597 | 3,357 | 7,954 | |
GPs (estimated)5,6,7 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)5,6,8 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total8 | 13,454,030 | 11,490,471 | 24,944,501 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- From 6 October 2021, people aged 12 years and older (birth years 2009 and before) with severely impaired immunity were invited for an extra vaccination supplementing their basic series, because they may not be able to build up sufficient immunity to COVID-19 from the basic series on its own. This involved patients who are being treated by a medical specialist for a specific condition or receiving certain prescription medication. An exact description is provided on the RIVM page about people with impaired immunity. They were invited via their medical specialist in the hospital. In total, this involves 133,308 vaccinations (data up to 27 February 2022). More information about the number of vaccinations can be found in Figure 1 in the update for 22 February 2022.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,147 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 8, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
22 February 2022 | 16:00
Vaccination figures 14 to 20 February 2021
Number of vaccinations in the basic series
By Sunday 20 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations. More than 133,000 third vaccinations were administered to people with severely impaired immunity.
Vaccination coverage for the basic series
It is estimated that 89.4% of all people over 18 have received at least one vaccination in the basic series, and 86.4% have completed the basic series. According to estimates, 87.7% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.9% have completed the basic series.
Number of booster vaccinations
By now, nearly 8.8 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.
Vaccination coverage for the booster vaccination
61.5% of all people over 18 have now received a booster vaccination.
Vaccination figures: 6 January 2021 – 20 February 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 7 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,777 | 67,213 | 135,99 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,416 | 187,505 | 377,921 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,199 | 374,391 | 753,59 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 576,002 | 567,916 | 1,143,918 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,781 | 844,243 | 1,708,024 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,558 | 780,483 | 1,586,041 |
GGD | 61-65 | 1956-1960 | 149,812 | 163,682 | 313,494 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,287 | 975,782 | 2,012,069 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,049,645 | 776,079 | 1,825,724 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,293 | 825,323 | 1,728,616 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 795,602 | 672,324 | 1,467,926 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 773,752 | 688,046 | 1,461,798 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 787,287 | 686,629 | 1,473,916 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 773,685 | 645,64 | 1,419,325 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,252,756 | 936,214 | 2,188,970 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 802,49 | 719,461 | 1,521,951 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 71,711 | 507 | 72,218 |
GGD | Unknown | Unknown | 4,639 | 3,407 | 8,046 | |
GPs (estimated)4,5,6 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)4,5,7 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total7 | 13,451,446 | 11,486,563 | 24,938,009 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVM. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,102 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 7, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.9% |
18 years and older | 2003 and before | 89.4% | 86.4% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
18 February 2022 | 17:00
Vaccination figures 7 to 13 February 2021
Number of vaccinations in the basic series
By Sunday 13 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations. About 133,000 third vaccinations have been administered to people with severely impaired immunity.
Vaccination coverage for the basic series
It is estimated that 89.3% of all people over 18 have received at least one vaccination in the basic series, and 86.4% have completed the basic series. According to estimates, 87.7% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.8% have completed the basic series.
Number of booster vaccinations
By now, more than 8.7 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service. Over 118,000 booster vaccinations were administered last week.
Vaccination coverage for the booster vaccination
61.1% of all people over 18 have now received a booster vaccination. Booster vaccination coverage increased by 1% in almost all age groups. As with the basic series, booster vaccination coverage is higher among older people than among young people.
As of this week, booster vaccination coverage among people over 18 is now available in a map at the level of the municipalities. Separate maps are also provided for the age groups of 18 to 59 years and of 60 years and older. The pattern of booster vaccination coverage per municipality is similar to that of the basic series. Vaccination coverage is somewhat higher in the east of the Netherlands than in the west. In the Randstad region along the west coast, booster vaccination coverage is somewhat lower in a number of larger cities than in the surrounding municipalities.
Vaccination figures: 6 January 2021 – 13 February 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 6 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,775 | 67,203 | 135,978 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,407 | 187,489 | 377,896 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,18 | 374,363 | 753,543 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,972 | 567,872 | 1,143,844 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,752 | 844,179 | 1,707,931 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,525 | 780,379 | 1,585,904 |
GGD | 61-65 | 1956-1960 | 149,762 | 163,576 | 313,338 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,036,199 | 975,606 | 2,011,805 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,049,556 | 775,86 | 1,825,416 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 903,178 | 825,079 | 1,728,257 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 795,442 | 672,02 | 1,467,462 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 773,504 | 687,604 | 1,461,108 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 786,957 | 685,927 | 1,472,884 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 773,341 | 644,817 | 1,418,158 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,252,236 | 934,962 | 2,187,198 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 802,148 | 718,352 | 1,520,500 |
GGD | 5-113 | 2010-2016 | 18 January 2022 | 69,683 | 254 | 69,937 |
GGD | Unknown | Unknown | 4,671 | 3,471 | 8,142 | |
GPs (estimated)4,5,6 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)4,5,7 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total7 | 13,447,042 | 11,480,731 | 24,927,773 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVMNational Institute for Public Health and the Environment. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 646,073 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 6, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.7% | 84.8% |
18 years and older | 2003 and before | 89.3% | 86.4% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
8 February 2022 | 16:00
Vaccination figures: 31 January 2022 to 6 February 2022
Number of vaccinations in the basic series
By Sunday 6 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations. About 133,000 third vaccinations have been administered to people with severely impaired immunity.
Vaccination coverage for the basic series
It is estimated that 89.3% of all people over 18 have received at least one vaccination in the basic series, and 86.3% have completed the basic series. According to estimates, 87.6% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.8% have completed the basic series.
Number of booster vaccinations
By now, more than 8.6 million booster vaccinations have been administered by Municipal Public Health Services (GGDs) and other vaccinators, such as hospitals, GPs or care institutions that have their own medical service.
Vaccination coverage for the booster vaccination
60.2% of all people over 18 have now received a booster vaccination.
Vaccination figures: 6 January 2021 – 6 February 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 5 (2022), by type of vaccinator.
Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|
91+ | 1930 and earlier | 26 January 2021 | 68,766 | 67,188 | 135,954 |
86-90 | 1931-1935 | 29 January 2021 | 190,400 | 187,462 | 377,862 |
81-85 | 1936-1940 | 5 February 2021 | 379,154 | 374,306 | 753,460 |
76-80 | 1941-1945 | 6 March 2021 | 575,939 | 567,816 | 1,143,755 |
71-75 | 1946-1950 | 6 April 2021 | 863,695 | 844,083 | 1,707,778 |
66-70 | 1951-1955 | 19 April 2021 | 805,465 | 780,250 | 1,585,715 |
61-65 | 1956-1960 | 149,681 | 163,434 | 313,115 | |
56-60 | 1961-1965 | 27 April 2021 | 1,036,069 | 975,314 | 2,011,383 |
51-55 | 1966-1970 | 20 May 2021 | 1,049,377 | 775,493 | 1,824,870 |
46-50 | 1971-1975 | 26 May 2021 | 902,994 | 824,720 | 1,727,714 |
41-45 | 1976-1980 | 29 May 2021 | 795,204 | 671,531 | 1,466,735 |
36-40 | 1981-1985 | 1 June 2021 | 773,132 | 686,965 | 1,460,097 |
31-35 | 1986-1990 | 7 June 2021 | 786,480 | 684,957 | 1,471,437 |
26-30 | 1991-1995 | 11 June 2021 | 772,702 | 643,627 | 1,416,329 |
18-25 | 1996-2003 | 15 June 2021 | 1,251,172 | 932,819 | 2,183,991 |
12-17 | 2004-2009 | 22 June 2021 | 801,323 | 715,960 | 1,517,283 |
5-113 | 2010-2016 | 18 January 2022 | 64,829 | 0 | 64,829 |
Unknown | Unknown | 4,757 | 3,591 | 8,348 | |
15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
13,437,893 | 11,471,234 | 24,909,127 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVMNational Institute for Public Health and the Environment. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 645,975 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 5, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.6% | 84.8% |
18 years and older | 2003 and before | 89.3% | 86.3% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
2 February 2022 | 16:00
Vaccination figures: 24 to 30 January 2022
Number of vaccinations in the basic series
By Sunday 30 January 2022, it is estimated that more than 24.8 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations. Nearly 133,000 third vaccinations have been administered to people with severely impaired immunity.
As of this week, the age group of 5-11 years is now included in the turnout for the first vaccination and vaccination coverage for the basic series. First vaccinations continue to be administered in all age groups. In this week, that gradual trend can primarily be observed in vaccination turnout among the age groups of 18-25 years and 86-90 years (+1%).
Vaccination coverage for the basic series
It is estimated that 89.3% of all people over 18 have received at least one vaccination in the basic series, and 86.3% have completed the basic series. According to estimates, 87.6% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.7% have completed the basic series.
Number of booster vaccinations
More than 8.4 million booster vaccinations have been administered by now. More than 7.4 million of these were administered by Municipal Public Health Services (GGDs). Other vaccinators, such as hospitals, GPs or care institutions that have their own medical service, have administered more than 951,000 booster vaccinations.*
Vaccination coverage for the booster vaccination
58.8% of all people over 18 have now received a booster vaccination, a 2.2% increase compared to last week. The increase is highest in the younger age groups.
* As of 1 February 2022, the number of booster vaccinations is based on vaccinations registered by the GGD, supplemented by booster vaccinations registered in CIMS (COVID Vaccination Information and Monitoring System) by other vaccinators than the GGD. Estimates are no longer used for the booster vaccinations.
Vaccination figures: 6 January 2021 – 30 January 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 4 (2022), by type of vaccinator.
Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|
91+ | 1930 and earlier | 26 January 2021 | 68,758 | 67,179 | 135,937 |
86-90 | 1931-1935 | 29 January 2021 | 190,389 | 187,439 | 377,828 |
81-85 | 1936-1940 | 5 February 2021 | 379,120 | 374,249 | 753,369 |
76-80 | 1941-1945 | 6 March 2021 | 575,877 | 567,740 | 1,143,617 |
71-75 | 1946-1950 | 6 April 2021 | 863,605 | 843,972 | 1,707,577 |
66-70 | 1951-1955 | 19 April 2021 | 805,366 | 780,092 | 1,585,458 |
61-65 | 1956-1960 | 149,582 | 163,239 | 312,821 | |
56-60 | 1961-1965 | 27 April 2021 | 1,035,875 | 974,930 | 2,010,805 |
51-55 | 1966-1970 | 20 May 2021 | 1,049,139 | 775,021 | 1,824,160 |
46-50 | 1971-1975 | 26 May 2021 | 902,761 | 824,210 | 1,726,971 |
41-45 | 1976-1980 | 29 May 2021 | 794,930 | 670,924 | 1,465,854 |
36-40 | 1981-1985 | 1 June 2021 | 772,719 | 686,188 | 1,458,907 |
31-35 | 1986-1990 | 7 June 2021 | 785,811 | 683,819 | 1,469,630 |
26-30 | 1991-1995 | 11 June 2021 | 771,916 | 642,142 | 1,414,058 |
18-25 | 1996-2003 | 15 June 2021 | 1,249,737 | 929,913 | 2,179,650 |
12-17 | 2004-2009 | 22 June 2021 | 800,062 | 712,467 | 1,512,529 |
5-113 | 2010-2016 | 18 January 2022 | 52,047 | 351 | 52,398 |
Unknown | Unknown | 4,945 | 3,812 | 8,757 | |
15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
13,419,393 | 11,459,405 | 24,878,798 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. Children aged 5-11 years receive a child dose of the COM vaccine.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Children aged 5-11 years in medical high-risk groups were eligible for vaccination as of late December 2021. Due to possible traceability of the data, these vaccinations were not reported to RIVMNational Institute for Public Health and the Environment. Children who received their first dose before 18 January 2022 are not included in this table (about 2000 vaccinations).
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 645,877 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 4, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.6% | 84.7% |
18 years and older | 2003 and before | 89.3% | 86.3% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 4 and 5 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage for the basic series’ is used to indicate the percentage of the population that has completed the basic series of COVID-19 vaccinations.
- The turnout for at least one dose and vaccination coverage for the basic series for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
25 January 2022 | 16:45
Vaccination figures: 17 to 23 January 2022
Number of vaccinations in the basic series
By Sunday 23 January 2022, it is estimated that more than 24.8 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations. In addition, nearly 133,000 third vaccinations were administered to people with severely impaired immunity.
Vaccination coverage for the basic series
It is estimated that 89.2% of all people over 18 have received at least one vaccination in the basic series, and 86.2% have completed the basic series. According to estimates, 87.6% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.7% have completed the basic series.
Number of booster vaccinations
More than 8 million booster vaccinations have been administered by now. More than 7.2 million of these were administered by Municipal Public Health Services (GGDs). It is estimated that other vaccinators, such as hospitals, GPs or care institutions that have their own medical service, have administered 859,000 booster vaccinations.
Vaccination coverage for the booster vaccination
It is estimated that 56.6% of all people over 18 have now received a booster vaccination. As of this week, we are also providing updates on booster vaccination coverage by age. Booster vaccination coverage is highest in older age groups. These age groups were the first to be invited for the booster vaccination.
Vaccination turnout among the age groups is rising faster for the booster vaccination than it did for the basic series. This is because the pace of vaccination is much faster for the booster. Vaccination coverage for the booster vaccination is currently much lower than vaccination coverage for the basic series of COVID-19 vaccinations. This is partly because the basic series must have been completed at least 3 months ago before a booster vaccination is administered. This is also partly because many people recently had COVID-19 and then have to wait three months before they can get a booster vaccination.
Vaccination figures: 6 January 2021 – 23 January 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 3 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,747 | 67,166 | 135,913 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,360 | 187,404 | 377,764 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,087 | 374,197 | 753,284 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,824 | 567,673 | 1,143,497 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,521 | 843,863 | 1,707,384 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,253 | 779,937 | 1,585,190 |
GGD | 61-65 | 1956-1960 | 149,467 | 163,021 | 312,488 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,035,679 | 974,504 | 2,010,183 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,048,904 | 774,521 | 1,823,425 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 902,497 | 823,643 | 1,726,140 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 794,583 | 670,226 | 1,464,809 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 772,239 | 685,301 | 1,457,540 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 784,972 | 682,401 | 1,467,373 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 770,857 | 640,400 | 1,411,257 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,248,026 | 926,802 | 2,174,828 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 798,542 | 707,959 | 1,506,501 |
GGD | Unknown | Unknown | 5,038 | 3,954 | 8,992 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,360,350 | 11,444,690 | 24,805,040 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 645,636 vaccinations administered by the GGD, involved JANSS. These vaccinations are only registered as a first dose, because the basic series is completed after one vaccination with the single-dose Janssen vaccine.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 3, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.6% | 84.7% |
18 years and older | 2003 and before | 89.2% | 86.2% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
18 January 2022 | 16:00
Vaccination figures: 10 to 16 January 2022
By Sunday 16 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.
Vaccination coverage for the basic series
It is estimated that 89.2% of all people over 18 have received at least one vaccination in the basic series, and 86.2% have completed the basic series. According to estimates, 87.5% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.6% have completed the basic series.
Major increase in number of booster vaccinations
By Sunday 16 January 2022, more than 7.7 million booster vaccinations and third vaccinations had been administered by the Municipal Public Health Services (GGDs) and other vaccinators. The GGD gave more than 6.7 million people their booster vaccination and more than 132,000 people with severely impaired immunity their third vaccination. It is estimated that other vaccinators, such as hospitals, GPs or care institutions that have their own medical service, administered a booster vaccination to another 827,000 people.
Vaccination coverage for the booster vaccination
It is estimated that 53.3% of all people over 18 have now received a booster vaccination. We expect to include booster vaccination coverage by age group in this update within the near future.
Vaccination figures: 6 January 2021 – 16 January 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 2 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,735 | 67,148 | 135,883 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,343 | 187,364 | 377,707 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,062 | 374,135 | 753,197 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,79 | 567,605 | 1,143,395 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,456 | 843,733 | 1,707,189 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,18 | 779,792 | 1,584,972 |
GGD | 61-65 | 1956-1960 | 149,38 | 162,797 | 312,177 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,035,519 | 974,032 | 2,009,551 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,048,672 | 773,899 | 1,822,571 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 902,218 | 822,824 | 1,725,042 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 794,222 | 669,258 | 1,463,480 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 771,69 | 684 | 1,455,690 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 784,039 | 680,684 | 1,464,723 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 769,731 | 638,508 | 1,408,239 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,246,213 | 923,365 | 2,169,578 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 796,622 | 704,667 | 1,501,289 |
GGD | Unknown | Unknown | 6,022 | 3,81 | 9,832 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,353,648 | 11,429,339 | 24,782,987 |
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 645,502 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 2, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.5% | 84.6% |
18 years and older | 2003 and before | 89.2% | 86.2% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
11 January 2022 | 16:00
Vaccination figures: 3 to 9 January 2022
By Sunday 9 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.
Vaccination coverage for the basic series
It is estimated that 89.1% of all people over 18 have received at least one vaccination in the basic series, and 86.1% have completed the basic series. According to estimates, 87.4% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.5% have completed the basic series.
Major increase in number of booster vaccinations
By 9 January, 6.6 million booster vaccinations and third vaccinations had been administered. More than 5.6 million people have received their booster vaccination from the Municipal Public Health Services (GGDs). In addition, by 9 January, an estimated 801,000 people had received a booster vaccination from other vaccinators, such as hospitals, GPs or care institutions that have their own medical service. Since 6 October 2021, about 132,000 people with severely impaired immunity received their third vaccination from the GGD.
Vaccination coverage for the booster vaccination
It is estimated that 45.2% of all people over 18 have now received a booster vaccination. Starting next week, we expect to include booster vaccination coverage by age group in this update.
Vaccination figures: 6 January 2021 – 9 January 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 (2021) to week 1 (2022), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,724 | 67,126 | 135,85 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,315 | 187,301 | 377,616 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 379,008 | 374,053 | 753,061 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,733 | 567,473 | 1,143,206 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,379 | 843,525 | 1,706,904 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,069 | 779,5 | 1,584,569 |
GGD | 61-65 | 1956-1960 | 149,266 | 162,419 | 311,685 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,035,294 | 973,169 | 2,008,463 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,048,358 | 772,787 | 1,821,145 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 901,872 | 821,516 | 1,723,388 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 793,767 | 668,06 | 1,461,827 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 771,001 | 682,544 | 1,453,545 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 782,922 | 678,75 | 1,461,672 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 768,261 | 636,139 | 1,404,400 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,243,845 | 919,002 | 2,162,847 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 793,809 | 700,604 | 1,494,413 |
GGD | Unknown | Unknown | 5,488 | 3,855 | 9,343 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,342,865 | 11,409,541 | 24,752,406 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, week 1, 2021 through week1, 2022, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 645,258 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to 1, 20221-5
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.4% | 84.5% |
18 years and older | 2003 and before | 89.1% | 86.1% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1, 2021 to week 1, 20221-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
4 January 2022| 4:00 PM
Vaccination figures: 27 December 2021 - 2 January 2022
By Sunday 2 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and nearly 11.4 million were second vaccinations.
Vaccination coverage for the basic series
It is estimated that 89.1% of all people over 18 have received at least one vaccination in the basic series, and 86.0% have completed the basic series. According to estimates, 87.4% of all people over 12 years old have now received at least one vaccination in the basic series, and 84.4% have completed the basic series.
Major increase in number of booster vaccinations
By Sunday 2 January 2022, more than 4.7 million booster vaccinations and third vaccinations had been administered. More than 3.8 million people have received their booster vaccination from the Municipal Public Health Services (GGDs). In addition, by 2 January, an estimated 731,000 people had received a booster vaccination from another vaccinator, such as hospitals, GPs or care institutions that have their own medical service. Since 6 October 2021, more than 131,000 people with severely impaired immunity have received their third vaccination from the GGD.
Vaccination coverage for the booster vaccination
It is estimated that 32.0% of all people over 18 have now received a booster vaccination.
Vaccination figures: 6 January 2021 – 2 January 2022
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 52 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,715 | 67,101 | 135,816 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,290 | 187,223 | 377,513 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 378,946 | 373,910 | 752,856 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,658 | 567,259 | 1,142,917 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,275 | 843,173 | 1,706,448 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 805,011 | 779,054 | 1,584,065 |
GGD | 61-65 | 1956-1960 | 149,136 | 161,863 | 310,999 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,035,079 | 972,050 | 2,007,129 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,048,028 | 771,641 | 1,819,669 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 901,464 | 820,111 | 1,721,575 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 793,236 | 666,527 | 1,459,763 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 770,361 | 680,809 | 1,451,170 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 781,700 | 676,354 | 1,458,054 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 766,678 | 633,286 | 1,399,964 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,241,314 | 913,841 | 2,155,155 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 788,700 | 694,740 | 1,483,440 |
GGD | Unknown | Unknown | 4,918 | 3,739 | 8,657 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,329,263 | 11,384,399 | 24,713,662 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 52, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 645,065 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.4% | 84.4% |
18 years and older | 2003 and before | 89.1% | 86.0% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 52, 20211-5
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.